Catalyst Biosciences Inc (CBIO) Stock Has Fallen -16.90% This Week: Buy, Hold, or Sell?

Wednesday, January 26, 2022 01:14 PM | InvestorsObserver Analysts

Catalyst Biosciences Inc (CBIO) stock is down -90.68% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives CBIO stock a score of 30 out of a possible 100. That rank is mainly influenced by a short-term technical score of 0. CBIO's rank also includes a long-term technical score of 0. The fundamental score for CBIO is 89. In addition to the average rating from Wall Street analysts, CBIO stock has a mean target price of $9.50. This means analysts expect the stock to rise 1510.17% over the next 12 months.

CBIO has an Overall Score of 30. Find out what this means to you and get the rest of the rankings on CBIO!

See Full CBIO Report

What's Happening with CBIO Stock Today

Catalyst Biosciences Inc (CBIO) stock is unchanged -0.1% while the S&P 500 is higher by 1.55% as of 1:12 PM on Wednesday, Jan 26. CBIO is unmoved $0.00 from the previous closing price of $0.59 on volume of 752,147 shares. Over the past year the S&P 500 has gained 14.92% while CBIO is down -90.68%. CBIO lost -$3.09 per share in the over the last 12 months. Click Here to get the full Stock Report for Catalyst Biosciences Inc stock.